Terms: = Gastric cancer AND CSF3R, CD114, 1441, ENSG00000119535, GCSFR AND Prognosis
3 results:
1. Development and validation of metabolic scoring to individually predict prognosis and monitor recurrence early in gastric cancer: A large-sample analysis.
Chen QY; Que SJ; Chen JY; Qing-Zhong ; Liu ZY; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng HL; Xie JW; Zheng CH; Li P; Huang CM
Eur J Surg Oncol; 2022 Oct; 48(10):2149-2158. PubMed ID: 35864012
[TBL] [Abstract] [Full Text] [Related]
2. Stromal score as a prognostic factor in primary gastric cancer and close association with tumor immune microenvironment.
Mao M; Yu Q; Huang R; Lu Y; Wang Z; Liao L
Cancer Med; 2020 Jul; 9(14):4980-4990. PubMed ID: 32432377
[TBL] [Abstract] [Full Text] [Related]
3. Different prognostic implication of ypTNM stage and pTNM stage for gastric cancer: a propensity score-matched analysis.
Li Z; Wang Y; Ying X; Shan F; Wu Z; Zhang L; Li S; Jia Y; Ren H; Ji J
BMC Cancer; 2019 Jan; 19(1):80. PubMed ID: 30651085
[TBL] [Abstract] [Full Text] [Related]
